Seven weeks of time-restricted eating plus home exercise did not improve VO2peak or glucose in women planning pregnancy
In 166 women at risk of gestational diabetes, 7 weeks of 10-hour eating windows plus mostly unsupervised exercise did not significantly change fitness or glucose.
Summary
Researchers in Norway randomized 166 women planning pregnancy, all at increased risk of gestational diabetes, to a lifestyle program or no intervention. The program combined eating within a 10-hour window with heart-rate-guided exercise, mostly done on their own. After 7 weeks, there was no statistically significant difference in cardiorespiratory fitness (VO2peak, a strong predictor of mortality) or in continuous glucose measures. About 60% kept to the eating window and 58% reached the exercise target, but only 47% met both. The intervention group also reported more evening hunger. Most women had normal glucose at baseline, leaving little room to improve. The result does not show the approach fails; earlier trials with supervised high-intensity training did report gains. It suggests unsupervised, home-based programs may be too weak to move these markers in a short time.
Detailed Summary
Cardiorespiratory fitness is among the strongest known predictors of all-cause mortality, and women entering pregnancy with low fitness and metabolic risk face higher odds of gestational diabetes and later cardiometabolic disease. Time-restricted eating (TRE) combined with high-intensity exercise improved fitness and glycemic markers in a prior 7-week trial in women with overweight or obesity, but that trial used supervised training. This secondary analysis of the BEFORE THE BEGINNING trial tested whether a mostly unsupervised version works in the preconception window.
The randomized, open-label trial in Trondheim, Norway enrolled 167 women aged 18-39 who planned to conceive within 6-12 months and had at least one GDM risk factor, with no diagnosed diabetes. After one exclusion, 166 were analyzed (intervention 83, control 83). Mean BMI was about 29 kg/m2 and baseline relative VO2peak about 36-37 mL/kg/min. The intervention was eating within 10 hours or less on at least 5 days per week, with last intake by 19:00, plus exercise guided by Personal Activity Intelligence (PAI) smartwatch scores, targeting at least 100 weekly points. Supervised sessions were offered only in weeks 1 and 3 and on request.
At 7 weeks, relative VO2peak differed by 0.8 mL/kg/min (95% CI -0.2 to 1.9, p=0.10) and absolute VO2peak by 0.1 L/min (p=0.17), neither significant. Glucose area under the curve did not differ (0.0 mmol-hour/L, 95% CI -0.1 to 0.2, p=0.76), and mean glucose, variability and excursions were also null across 24-hour, daytime and nocturnal periods. Nocturnal AUC trended lower (-0.2 mmol-hour/L, p=0.08 at week 1 and p=0.13 at week 7) but was not significant. The prespecified threshold was p<0.01 given multiple secondary outcomes.
Behavior did change. The intervention group shortened its eating window by about 2 hours, 60% (50 of 83) kept to 10 hours or less, and mean weekly PAI was 117, with 58% reaching at least 75 points. Armband data showed 0.8 more minutes of very vigorous activity daily in week 1 (p=0.001), and self-reported sitting fell by 115 minutes weekly (p=0.007). Steps did not differ significantly at the stricter threshold. Participants reported greater evening hunger, lower satiety and higher appetite. No serious adverse events occurred; skin irritation from devices was minor.
Only 39 of 83 (47%) met both adherence criteria, and per-protocol results matched the intention-to-treat results. The authors suggest home-based programs may have limited short-term cardiometabolic impact and that supervised or higher-intensity training may be needed. This is a null on fitness and glucose at 7 weeks, not on longer-term outcomes, which are covered in the main trial.
Caveats matter. Participants had mostly normal glucose at baseline, limiting room for improvement. The trial was powered for the primary pregnancy outcome, not these secondary ones, and was unblinded. Actual exercise intensity was modest, and protocol changes occurred during recruitment. The confidence intervals for VO2peak still include a possible benefit of about 2 mL/kg/min, so the study cannot exclude a small real effect.
Key Findings
- Relative VO2peak difference of 0.8 mL/kg/min (95% CI -0.2 to 1.9, p=0.10) at 7 weeks; not significant
- Glucose AUC difference 0.0 mmol-hour/L (95% CI -0.1 to 0.2, p=0.76); no CGM measure differed between groups
- 166 women analyzed (83 per arm), mean BMI about 29, baseline mean glucose about 4.8-4.9 mmol/L
- 60% (50/83) kept to a 10-hour eating window; mean weekly PAI 117, 58% reached at least 75 points; only 47% met both targets
- Very vigorous activity rose 0.8 min/day in week 1 (p=0.001); self-reported sitting fell 115 min/week (p=0.007)
- Intervention group reported greater evening hunger, lower satiety and higher appetite
- Per-protocol results (n=39) matched intention-to-treat; no serious adverse events
Methodology
Two-arm, parallel-group, open-label RCT in Trondheim, Norway, with 1:1 randomization stratified by prior GDM; 166 women were analyzed. VO2peak was measured by treadmill indirect calorimetry and glucose by 14-day FreeStyle Libre CGM, with 7-week follow-up. Linear mixed models were used, with bootstrap CIs for non-normal data and a conservative significance threshold of p<0.01 for these exploratory secondary outcomes. Sample size was based on the primary outcome (2-hour OGTT glucose at gestational week 28), not these endpoints.
Study Limitations
The study may be underpowered for secondary outcomes, was unblinded, and had protocol modifications during recruitment (supervised sessions, devices, exclusion criteria). Most participants had normal baseline glucose, limiting room for improvement, and only 47% met both adherence criteria. Exercise supervision was minimal, and armband monitoring covered only the first intervention week.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
